News

Taken together, the findings suggest that targeted augmentation of cholinergic signalling may help bridge the gap between anatomical de-obstruction and functional recovery in BOO-mediated UAB.

A large pooled analysis shows that kidney problems are common in PAH and CTEPH, worsen survival, and see only minor improvement with current pulmonary hypertension therapies.

Dopamine changes link to psychotic symptoms, suggesting new treatment avenues for mood disorders with psychosis.

A new bispecific antibody therapy, AFM28, has shown strong preclinical results in targeting treatment-resistant cells in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), according to new research.

Intermittent fasting decreased symptoms of long COVID-19 in a randomised crossover trial that compared the efficacy and safety of 4 weeks of 1–2-day fasting plus a restricted diet versus 4 weeks of mild time-restricted eating and a restricted diet

Silymarin, vitamin E, and phospholipids combination therapy effectively reduces liver steatosis, fibrosis, and metabolic risk in MASLD.

Discover how stopping smoking may improve recovery from other addictions and why treatment programmes should integrate both.

A new study reveals that over a third of Indian rheumatoid arthritis patients experience methotrexate intolerance, with many reporting symptoms like nausea and abdominal discomfort.